SPARC, FOXP3, CD8 and CD45 Correlation with Disease Recurrence and Long-Term Disease-Free Survival in Colorectal Cancer

• Angela Chew,

  Affiliations Centre for Inflammatory Bowel Diseases, Fremantle Hospital, Fremantle, Western Australia, Australia, School of Medicine and Pharmacology, University of Western Australia, Fremantle, Western Australia, Australia

  ⨯
• Paul Salama,

  Affiliation School of Surgery, University of Western Australia, Nedlands, Western Australia, Australia

  ⨯
• Anneli Robbshaw,

  Affiliation Centre for Inflammatory Bowel Diseases, Fremantle Hospital, Fremantle, Western Australia, Australia

  ⨯
• Borut Klopcic,

  Affiliations Centre for Inflammatory Bowel Diseases, Fremantle Hospital, Fremantle, Western Australia, Australia, School of Medicine and Pharmacology, University of Western Australia, Fremantle, Western Australia, Australia

  ⨯
• Nikolajs Zeps,

  Affiliations School of Surgery, University of Western Australia, Nedlands, Western Australia, Australia, Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia, St John of God Pathology, Subiaco, Western Australia, Australia

  ⨯
• Cameron Platell,

  Affiliations School of Surgery, University of Western Australia, Nedlands, Western Australia, Australia, St John of God Colorectal Service, Subiaco, Western Australia, Australia

  ⨯
• Ian C. Lawrance

  * E-mail: Ian.Lawrance@uwa.edu.au

  Affiliations Centre for Inflammatory Bowel Diseases, Fremantle Hospital, Fremantle, Western Australia, Australia, School of Medicine and Pharmacology, University of Western Australia, Fremantle, Western Australia, Australia

  ⨯